|
QuintilesIMS Real-World Insights Bibliography
| Liver transplant associated with paracetamol overdose: results from the seven-country SALT study |
| Author(s): Sinem Ezgi Gulmez,1 Dominique Larrey,2 Georges-
Philippe Pageaux,2 Jacques Bernuau,3 Franco Bissoli,4
Yves Horsmans,5 Douglas Thorburn,6 P. Aiden McCormick,7
Bruno Stricker,8 Massoud Toussi,9 Séverine Lignot-Maleyran,1
Sophie Micon,1 Fatima Hamoud,1 Régis Lassalle,1 Jérémy Jové,1
Patrick Blin1 & Nicholas Moore1 |
| Affiliations(s): 1CIC Bordeaux CIC1401 Pharmaco-épidémiologie, Université de Bordeaux, F-33076 Bordeaux,
France, 2CHU St Eloi Hospital, Liver Unit, Montpellier, France, 3Beaujon Hospital, Liver Unit, Clichy,
France, 4Department of Internal Medicine, Clinica San Gaudenzio, Novara, Italy, 5Department of
Gastroenterology, Louvain Catholic University, Louvain, Belgium, 6Liver Unit, Royal Free NHS Trust,
London, UK, 7Liver Unit, St Vincent’s University Hospital and University College Dublin, Dublin,
Ireland, 8Department of Epidemiology, Erasmus University, Rotterdam, Netherlands and 9IMSHealth, Real World Evidence Solutions, France |
| Publication(s): British Journal of Clinical Pharmacology 2015 |
| Document Type(s): Article |
| Countries: France, Greece, Ireland, Italy, Netherlands, Portugal, UK |
C:
Y: |
Drug safety, Public Health
2015 |
|
L:
A: |
English
Epidemiological study |
|
 |
| |
| |
| A health economic evaluation of Omega-3 ethyl esters 0 in the secondary prevention post- MI. |
| Author(s): Gerlier L1, Vellopoulou K1, Lamotte M1, Lacey L2, Einroos A3, Carr E4 |
| Affiliations(s): 1 IMS Health, Vilvoorde, Belgium 2 Lacey Solutions Ltd, Skerries, Ireland 3 Abbott Laboratories, Tallinn, Estonia 4 Abbott Laboratories, Allschwil, Switzerland |
| Publication(s): 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
| Document Type(s): Abstract, Poster |
| Countries: Estonia, Ireland |
C:
Y: |
Cardiovascular disease
2012 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Cost-effectiveness of Tapentadol prolonged-release (PR) compared to Oxycodone controlled release (CR) in patients with chronic severe non-cancer pain in Ireland |
| Author(s): Obradovic M1, Ikenberg R2, Hertel N3, Liedgens H1 |
| Affiliations(s): 1Grünenthal GmbH, Aachen, Germany, 2IMS Health GmbH Und Co. Ohg, Nürnberg, Germany, 3IMS Health, London, UK |
| Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
| Document Type(s): Poster |
| Countries: Ireland |
C:
Y: |
Miscellaneous
2011 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Cost-effectiveness of Tapentadol prolonged-release (PR) compared to oxycodone controlled release (CR) in patients with chronic severe non-cancer pain in Ireland |
| Author(s): Obradovic M.1, Ikenberg R.2, Hertel N.3, Liedgens H.1 |
| Affiliations(s): 1 Grünenthal GmbH, Aachen, Germany, 2 IMS Consulting Group, Nuremberg, Germany, 3 IMS Consulting Group, London, UK |
| Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
| Document Type(s): Poster |
| Countries: Ireland |
C:
Y: |
Pricing and reimbursement
2011 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
|
|
|
